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A 28-year-old female who underwent live donor liver transplantation 3 years prior presented after percutaneous liver biopsy with
abdominal and shoulder pain, nausea, vomiting, and elevated liver enzymes. Computed tomography (CT) showed an intrahepatic
and subcapsular hematoma. There was a progressive increase in liver enzymes, bilirubin, and INR and a decline in hemoglobin.
SubsequentCTimagingrevealedﬂatteningoftheportalveinconsistentwithcompressionbytheenlarginghematoma.Liverfailure
ensued and the patient required urgent retransplantation. The explant demonstrated ischemic necrosis of greater than 90% of the
liver parenchyma. We report this case of “Hepatic Compartment Syndrome” leading to fulminant hepatic failure.
1.Introduction
Percutaneous liver biopsy is routinely performed in the
posttransplant setting for elevated liver enzymes of unclear
etiology. Complications requiring hospitalization occur in
1.4%–3.2% of percutaneous biopsies [1, 2]. Although
asymptomatic bleeding can be detected by ultrasound in up
to 23% of cases, signiﬁcant bleeding occurs in only 0.078%–
0.32% of percutaneous liver biopsies [3–5]. Mortality is rare,
seen in 1 in 10,000–12,000 cases [5, 6].
Wereportacaseofintrahepaticandsubcapsularbleeding
after liver biopsy causing compression of the portal vein
and massive ischemic hepatic necrosis. We postulate that the
expanding hematoma led to elevated intrahepatic pressures
that in turn resulted in diminished hepatic perfusion and
ischemia. This “Hepatic Compartment Syndrome” led to
fulminant hepatic failure requiring emergent liver transplan-
tation.Thisetiologyoffulminanthepaticfailurehasnotbeen
previously reported.
2.CaseReport
A 28-year-old female underwent adult-to-adult live donor
liver transplant (AALDLT) for vertically acquired genotype 1
hepatitis C-related cirrhosis. The early postoperative course
was uneventful. She developed elevated liver chemistries
and underwent a percutaneous liver biopsy demonstrating
histologic recurrence of HCV within 8 months of transplant.
Sheunderwent2coursesoftherapywithpegylatedinterferon
alfa-2b and ribavirin. She relapsed after the ﬁrst course of
48 weeks of therapy; she was retreated shortly after that
with the same regimen for 17 months and subsequently
achieved a sustained virologic response. She did well with
no changes in immune suppression or the development
of other medical issues for 5 years post transplant (3
years after completion of HCV therapy). At that point,
aminotransferases increased for unclear reasons (aspartate
aminotransferase (AST) 106U/L, alanine aminotransferase
(ALT) 177U/L) from a baseline of less than 30U/L. Hepatitis2 Journal of Transplantation
C PCR tests, using a qualitative lower limit of detection of
50IU/mL, were repeatedly negative. Due to the unexplained
elevation in aminotransferases she was scheduled for liver
biopsy. The only medications at that time were tacrolimus
and Ortho Tri-Cyclen, and the patient denied herbal or
alternative medications. Relevant additional past medical
history was signiﬁcant only for previous short segment small
bowelresectionforpossibleinﬂammatoryboweldisease;this
eventwasnottemporallyrelatedtothe elevatedenzymesand
histology revealed nonspeciﬁc bowel inﬂammation.
Percutaneous ultrasound-guided right lobe liver biopsy
was performed using a 15-guage core biopsy device by an
experienced radiologist. Prior to the procedure, the patient
was noted to be hypertensive with systolic blood pressure
of 160–190 and diastolic pressures of 100–120. This was
attributed to anxiety and her pressure normalized with an
anxiolytic. The procedure was performed in the morning
and was uneventful, and the patient’s vital signs were normal
after the biopsy. She was discharged home after a four-hour
observation period. Histology revealed nonspeciﬁc mild
portal inﬂammation, no ﬁbrosis, and minimal endotheliitis
and rare eosinophils raising the possibility of mild acute
cellular rejection.
The evening of the same day the patient developed
mild right shoulder pain. The pain awakened her at 4
a.m. (roughly 20 hours post biopsy) and at this point
was severe, in the shoulder and right upper quadrant,
and accompanied by nausea and vomiting. On readmission
through the emergency department, she had normal vital
signs and her exam was notable for tenderness over the
right upper quadrant. Laboratory values were notable for
AST 810U/L, ALT 772U/L, alkaline phosphatase 227U/L,
bilirubin1.8mg/dL,prothrombin(PT)INR1.0,hemoglobin
14.6g/dL, hematocrit 41.3%, platelets 109,000/UL, BUN
18mg/dL,andcreatinine0.7mg/dL.Nofreeairwasnotedon
plain abdominal X-rays. A computerized tomography (CT)
scan of the abdomen revealed a hyperdense mass within the
right lobe of the liver, measuring 7.7 × 5.7cm in diameter,
traversing segments 6 and 7 and bordering on segment 8. In
addition, there was a hypodense region within segment 8 in
a subcapsular distribution which was felt to also represent
hemorrhage or an area of infarction of the liver (Figure 1).
Approximately 12 hours after admission (30 hours
post biopsy), hemoglobin was 11.9g/dL, AST 4947U/L,
ALT 4447U/L, total bilirubin 4.3mg/dL, and PT INR 2.1.
She was transferred to the Medical Intensive Care Unit.
Repeated CT scan demonstrated a slight increase in the
anterolateral subcapsular hematoma, with decreased density
of the parenchyma, and ﬂattening and eﬀacement of the
inferior vena cava and portal veins consistent with com-
pression by the enlarging hematoma. A celiac arteriogram
was performed and revealed that the anterior and posterior
branches of the right hepatic artery were attenuated and
displaced medially due to large hematoma in the right lobe
of the liver, but the hepatic artery was patent. Selective
angiograms in the anterior and posterior branches of the
right hepatic artery failed to show any active bleeding or
pseudoaneurysm (Figure 2).
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Figure 1: (a) CT scan demonstrating extensive intraparenchymal
hematoma and compression of portal vein (PV) branches; (b) for
comparison, a CT scan from the same patient from 2 years prior
shows the normal appearance of a right lobe graft with normal
portal vein branches.
10cm
Figure 2: Hepatic arteriogram demonstrating medial displacement
of hepatic arterioles due to mass eﬀect of hematoma and lack of any
arterial bleeding site.
Within 24 hours of admission her clinical picture
changed; she developed encephalopathy, tachypnea, and
a decrease in hemoglobin to 8.9g/dL. Other pertinent
laboratory values included AST >6000U/L, ALT >8000U/L,
total bilirubin 4.8mg/dL, INR 2.2, Cr 1.7mg/dL, and a pH
7.07. She was intubated and a bicarbonate drip was started
to correct the acidosis. Over the next 24 hours, the PT INRJournal of Transplantation 3
Figure 3: Gross photo of explanted liver demonstrating large area
of hemorrhage and necrosis.
Figure 4: Photomicrograph of explanted liver demonstrating
massive necrosis and architectural collapse.
rose to 5.5, total bilirubin increased to 15.5mg/dL, and her
mental status and acidosis worsened. She required 16 units
of packed red blood cells, 24 units of fresh frozen plasma,
hemodynamic support with pressors, and hemodialysis for
acute renal failure. She was listed emergently for liver
transplantation.
Approximately 72 hours after admission she underwent
orthotopic liver transplantation (OLT). Her liver was densely
adherent to the abdominal wall and had a large hematoma
along the capsule, extending over 15cm of the surface,
creating a ﬁrm and immobile liver. The main hepatic
artery had evidence of acute thrombus (which was not
present at angiogram). Explant demonstrated hemorrhage
and adhesions of the serosa, multiple areas of ischemic
necrosis occupying greater than 90% of the parenchyma,
focal acute parenchymal hemorrhage, and central hematoma
(Figures 3 and 4). After transplantation the patient’s liver
tests normalized, her renal failure improved, and she was
discharged home on postoperative day 13.
3. Discussion
Percutaneous liver biopsy is considered a relatively safe
procedure with an overall complication rate of 0.9%–3.7%
with the most feared complication being that of major
hemorrhage [1]. The risk of bleeding ranges from 0.06%
to 1.7% and the risk of death (generally from bleeding)
from 0.009% to 0.48% [4, 6–9]. Posttransplant biopsies have
similar complication rates [10, 11].
Signiﬁcant bleeding after liver biopsy is typically in the
form of hemoperitoneum (0.32%) as opposed to intra-
hepatic hematoma (0.023%) [4, 5]. The incidence of mild
asymptomatic bleeding is signiﬁcantly higher than detected
bleeding. Minuk et al. reported small hematomas seen
via ultrasound in 23% of patients one day after biopsy
[3]. Two prospective series have demonstrated intrahepatic
hematomas on liver scan in 2% to 7% of subjects after
biopsy [12, 13]. Vascular defects such as arteriovenous
shunts and occluded arteries have also been reported. In
1976, Hellekant showed angiographic defects in 61% of
patients within 1 week of biopsy, but in only 11% of
angiograms done after one week [14]. Subsequent studies
of angiography after percutaneous liver biopsy have shown
arteriovenous ﬁstulae, mostly arterioportal, in 5.4%–6.3%
of patients within one week to one month of the procedure
[15, 16]. Most arterioportal ﬁstulae are asymptomatic and
close spontaneously [16].
Complications of liver biopsy typically manifest within
24 hours, with 61% occurring within 2 hours and 96%
becoming evident within 24 hours [4]. Bleeding generally
results from laceration of Glisson’s capsule or intrahepatic
hematoma.Increasedriskofbleedingisassociatedwitholder
age, underlying malignancy, cirrhosis, and increasing num-
ber of biopsy passes [4, 6]. Hemoperitoneum is associated
withahigherdeathrateinthosewithmalignancyorcirrhosis
[4, 6].
There are few published reports of intrahepatic hema-
tomas resulting in death following liver biopsy [17]. Ahmed
et al. report a case of hemorrhage from a hepatic artery
pseudoaneurysm after liver biopsy. Bleeding continued
despite embolization of the actively bleeding right hepatic
arterial branch at initial angiography. Subsequent angiogra-
phy showed new areas of active bleeding and laceration of
the right hepatic lobe. Surgical oversewing and packing of
the laceration were performed at laparotomy; however, the
patient succumbed to multiorgan failure. Autopsy revealed
foci of necrosis throughout both lobes of the liver, with the
right lobe being almost entirely necrotic [18].
Thisistheﬁrstreportedcaseofpercutaneousliverbiopsy
resulting in a rapidly expanding hematoma with subsequent
vascular compromise and acute liver failure. The initial
CT scan within 24 hours of biopsy demonstrated portal
vein compression. Hepatic arteriogram demonstrated patent
hepatic arterial ﬂow, but, 48 hours later, at the time of
liver transplantation the hepatic artery had thrombosed. We
postulate that the expanding hematoma in the presence of an
intact hepatic capsule led to climbing intrahepatic pressure.
This in turn caused pressure necrosis of hepatic parenchyma
and compromised portal ﬂow, while increased vascular
resistance and vasoconstriction likely led to hepatic artery
thrombosis. We believe this syndrome should be termed
“Hepatic Compartment Syndrome” due to its similarity to
the well-described abdominal compartment syndrome. In
abdominal compartment syndrome, increased abdominal
pressure leads to compromised perfusion through mech-
anisms including both increased pressure on abdominal4 Journal of Transplantation
visceraandvesselscompromisedbycardiacoutput.Similarly
in hepatic compartment syndrome, it is likely that hepatic
parenchymal pressure, hepatic necrosis, and hypovolemia
work in concert to compromised hepatic perfusion.
It is noteworthy that this condition developed in the
setting of prior right lobe live donor liver transplant.
Transplanted livers typically develop a dense adherence to
the surrounding diaphragm and peritoneal surfaces which
usually is only relevant if the patient requires retransplan-
tation. In this case, the inability of the thickened capsule
to expand likely contributed to the compartment syndrome.
Transplanted livers may be more sensitive to blood ﬂow
compromisethanthenativelivereitherbythelossofvascular
autoregulation or the loss of collateral ﬂow. Additionally, a
partial liver graft may be even more susceptible to vascular
compromise, particularly hepatic artery thrombosis, due to
the lack of a large contralateral vascular bed to allow for
lateral shunting in cases of increased resistance. This is
speculative; however, no data exists to support this.
In summary, the constellation of rapidly expanding
intrahepatic hematoma with hepatic vascular compromise
and hepatic necrosis deﬁne hepatic compartment syndrome.
The case presented resulted in fulminant hepatic failure
requiring retransplantation, but certainly lesser degrees of
hepatic injury could result. Whether this rare phenomenon
is more likely to occur after either whole or live donor liver
transplantation remains unknown.
Percutaneous biopsy remains an extremely safe and
important tool for managing the transplant patient, as
severe bleeding or complication is rare. Keys to management
include early recognition, hepatic angiogram to seek a
bleeding arterial source, hemodynamic support and, as in
this case, timely liver transplantation when hepatic failure is
irreversible.
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